nad has been researched along with Carcinoma, Ductal, Pancreatic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Q; Gong, J; He, X; Li, Y; Lin, C; Lou, J; Wu, Y; Zheng, L; Zhu, Y | 1 |
Ackenhusen, SE; Andren, A; Chen, B; Crawford, HC; Galban, S; Gao, X; Halbrook, CJ; Hoffman, MT; Jiménez, JA; Kemp, SB; Kerk, SA; Lin, L; Lombard, DB; Long, D; Lyssiotis, CA; Myers, AL; Nelson, BS; Nwosu, ZC; Pasca di Magliano, M; Piwnica-Worms, DR; Ramos, J; Robinson, A; Sajjakulnukit, P; Shah, YM; Steele, NG; Sutton, DJ; Thurston, G; Wen, HJ; Ying, H; Zhang, L; Zhang, Y | 1 |
Abt, ER; Cui, J; Dann, AM; Dawson, DW; Donahue, TR; Elliott, I; Ghukasyan, R; Khachatourian, N; Kim, S; Le, T; Li, L; Liang, K; Moore, AM; Pagano, K; Poddar, S; Radu, CG; Riahi, R; Wu, N; Yu, A; Zhou, L | 1 |
Guan, KL; Lin, H; Ling, ZQ; Shi, Q; Xiong, Y; Yang, H; Yang, Y; Ye, D; Zhang, M; Zhao, S; Zhao, Y; Zhou, L | 1 |
Chiao, PJ; Fan, XQ; Ju, HQ; Li, H; Lu, YX; Mo, HY; Sheng, H; Tian, T; Xu, RH; Zhou, HJ; Zhuang, ZN | 1 |
5 other study(ies) available for nad and Carcinoma, Ductal, Pancreatic
Article | Year |
---|---|
O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction.
Topics: Autoantigens; Carcinoma, Pancreatic Ductal; Cell Proliferation; Humans; N-Acetylglucosaminyltransferases; NAD; Pancreatic Neoplasms; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Serine; Sirtuins | 2022 |
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context.
Topics: Animals; Aspartate Aminotransferase, Mitochondrial; Carcinoma, Pancreatic Ductal; Fatty Acid-Binding Proteins; Humans; Mice; NAD; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Pyruvic Acid; Tumor Microenvironment | 2022 |
NAD
Topics: Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Proliferation; Cytokines; Gene Expression Regulation, Neoplastic; Humans; Interferon Type I; Male; Mice; Mice, Inbred NOD; Mice, SCID; NAD; Neoplasm Proteins; Nicotinamide Phosphoribosyltransferase; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.
Topics: Acetylation; Animals; Aspartate Aminotransferase, Mitochondrial; Aspartic Acid; Biological Transport; Carcinoma, Pancreatic Ductal; Cell Proliferation; Cells, Cultured; HEK293 Cells; Humans; Malates; Male; Mice; Mice, Inbred C57BL; Mice, Nude; NAD; Oxidation-Reduction; Pancreatic Neoplasms; Protein Processing, Post-Translational; Sirtuin 3 | 2015 |
Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer.
Topics: 3' Untranslated Regions; Acrylamides; Animals; Antimetabolites, Antineoplastic; Binding Sites; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cytokines; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Gemcitabine; Glycolysis; Humans; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; MicroRNAs; NAD; Nicotinamide Phosphoribosyltransferase; Pancreatic Neoplasms; Piperidines; RNA Interference; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |